Institute of Human Nutrition and Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
Curr Opin Lipidol. 2013 Aug;24(4):345-50. doi: 10.1097/MOL.0b013e3283616364.
This article provides an updated review on mechanistic and molecular studies relating to the effects of n-3 fatty acids (FA) on inhibiting atherogenesis.
The effects of n-3 FA on modulating arterial lipoprotein lipase levels link to changes in lipid deposition in the arterial wall. Lipoprotein lipase expression in the arterial wall also relates to local macrophage-mediated inflammatory processes. Increasing evidence suggests that n-3 FA ameliorate inflammation, another key component in the development of atherosclerosis, including decreases in proinflammatory cytokine production. n-3 FA inhibit atherogenic signaling pathways and modulate the phenotypes of inflammatory leukocytes and their recruitment in the arterial wall.
New mechanistic insights into the antiatherogenic action of n-3 FA have emerged. These studies may contribute to future therapeutic advances in preventing mortality and morbidity associated with atherosclerosis.
本文就 n-3 脂肪酸(FA)在抑制动脉粥样硬化方面的作用的机制和分子研究进行了最新综述。
n-3 FA 对调节动脉脂蛋白脂肪酶水平的影响与动脉壁脂质沉积的变化有关。动脉壁中的脂蛋白脂肪酶表达也与局部巨噬细胞介导的炎症过程有关。越来越多的证据表明,n-3 FA 改善炎症,这是动脉粥样硬化发展的另一个关键组成部分,包括减少促炎细胞因子的产生。n-3 FA 抑制动脉粥样硬化信号通路,并调节炎症性白细胞的表型及其在动脉壁中的募集。
n-3 FA 的抗动脉粥样硬化作用的新机制见解已经出现。这些研究可能有助于未来在预防与动脉粥样硬化相关的死亡率和发病率方面取得治疗进展。